Showing results (161-170 of 185) with videos related to
Sort By:
Pageof 19
International Journal of Oncology|June 9, 2005
Expression of transcription factor Yin Yang 1 in prostate cancerDavid Seligson, Steve Horvath, Sara Huerta-Yepez, et al.Blood|June 29, 2006
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptorPatrick P Ng, Gustavo Helguera, Tracy R Daniels, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cellsStavroula Baritaki, Eriko Suzuki, Kazuo Umezawa, et al.Forum on Immunopathological Diseases and Therapeutics|November 29, 2013
Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple MyelomaStavroula Baritaki, Sara Huerta-Yepez, Ma da Lourdas Cabrava-Haimandez, et al.Cancer Biomarkers : Section a of Disease Markers|September 5, 2009
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcomeNam K Yoon, David B Seligson, David Chia, et al.International Journal of Oncology|June 2, 2010
A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assayHaiming Chen, Cathy S Wang, Mingjie Li, et al.Plos One|March 25, 2014
Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancerSaad Yousuf, MeiLi Duan, Erika L Moen, et al.British Journal of Haematology|June 26, 2007
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acidRichard A Campbell, Eric Sanchez, Jeffrey A Steinberg, et al.BMC Cancer|October 18, 2015
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaGabriel G Vega, Alejandro Avilés-Salas, J Ramón Chalapud, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functionsMario I Vega, Sara Huerta-Yepez, Melisa Martinez-Paniagua, et al.Pageof 19